img

Global Oral Anticoagulant Reversal Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Oral Anticoagulant Reversal Drug Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Oral Anticoagulant Reversal Drug Market
Global Oral Anticoagulant Reversal Drug market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Oral Anticoagulant Reversal Drug industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
According to the Global Use of Medicines 2024 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2024 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
Report Covers
This report presents an overview of global Oral Anticoagulant Reversal Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Oral Anticoagulant Reversal Drug market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Bausch Health Companies
Pfizer
Fresenius Kabi
Amneal Pharmaceuticals
Boehringer Ingelheim
CSL
Octapharma
Portola Pharmaceuticals
Perosphere Pharmaceuticals
Segment by Type
Prothrombin Complex Concentrates
Vitamin K
Protamine
Tranexamic Acid

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Oral Anticoagulant Reversal Drug introduction, etc. Oral Anticoagulant Reversal Drug Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Oral Anticoagulant Reversal Drug
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Anticoagulant Reversal Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Prothrombin Complex Concentrates
1.2.3 Vitamin K
1.2.4 Protamine
1.2.5 Tranexamic Acid
1.3 Market by Application
1.3.1 Global Oral Anticoagulant Reversal Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Anticoagulant Reversal Drug Market Perspective (2018-2029)
2.2 Global Oral Anticoagulant Reversal Drug Growth Trends by Region
2.2.1 Oral Anticoagulant Reversal Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Oral Anticoagulant Reversal Drug Historic Market Size by Region (2018-2024)
2.2.3 Oral Anticoagulant Reversal Drug Forecasted Market Size by Region (2024-2029)
2.3 Oral Anticoagulant Reversal Drug Market Dynamics
2.3.1 Oral Anticoagulant Reversal Drug Industry Trends
2.3.2 Oral Anticoagulant Reversal Drug Market Drivers
2.3.3 Oral Anticoagulant Reversal Drug Market Challenges
2.3.4 Oral Anticoagulant Reversal Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Oral Anticoagulant Reversal Drug by Players
3.1.1 Global Oral Anticoagulant Reversal Drug Revenue by Players (2018-2024)
3.1.2 Global Oral Anticoagulant Reversal Drug Revenue Market Share by Players (2018-2024)
3.2 Global Oral Anticoagulant Reversal Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Oral Anticoagulant Reversal Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Oral Anticoagulant Reversal Drug Market Concentration Ratio
3.4.1 Global Oral Anticoagulant Reversal Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Anticoagulant Reversal Drug Revenue in 2022
3.5 Global Key Players of Oral Anticoagulant Reversal Drug Head office and Area Served
3.6 Global Key Players of Oral Anticoagulant Reversal Drug, Product and Application
3.7 Global Key Players of Oral Anticoagulant Reversal Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Anticoagulant Reversal Drug Breakdown Data by Type
4.1 Global Oral Anticoagulant Reversal Drug Historic Market Size by Type (2018-2024)
4.2 Global Oral Anticoagulant Reversal Drug Forecasted Market Size by Type (2024-2029)
5 Oral Anticoagulant Reversal Drug Breakdown Data by Application
5.1 Global Oral Anticoagulant Reversal Drug Historic Market Size by Application (2018-2024)
5.2 Global Oral Anticoagulant Reversal Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Oral Anticoagulant Reversal Drug Market Size (2018-2029)
6.2 North America Oral Anticoagulant Reversal Drug Market Size by Type
6.2.1 North America Oral Anticoagulant Reversal Drug Market Size by Type (2018-2024)
6.2.2 North America Oral Anticoagulant Reversal Drug Market Size by Type (2024-2029)
6.2.3 North America Oral Anticoagulant Reversal Drug Market Share by Type (2018-2029)
6.3 North America Oral Anticoagulant Reversal Drug Market Size by Application
6.3.1 North America Oral Anticoagulant Reversal Drug Market Size by Application (2018-2024)
6.3.2 North America Oral Anticoagulant Reversal Drug Market Size by Application (2024-2029)
6.3.3 North America Oral Anticoagulant Reversal Drug Market Share by Application (2018-2029)
6.4 North America Oral Anticoagulant Reversal Drug Market Size by Country
6.4.1 North America Oral Anticoagulant Reversal Drug Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Oral Anticoagulant Reversal Drug Market Size by Country (2018-2024)
6.4.3 North America Oral Anticoagulant Reversal Drug Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Oral Anticoagulant Reversal Drug Market Size (2018-2029)
7.2 Europe Oral Anticoagulant Reversal Drug Market Size by Type
7.2.1 Europe Oral Anticoagulant Reversal Drug Market Size by Type (2018-2024)
7.2.2 Europe Oral Anticoagulant Reversal Drug Market Size by Type (2024-2029)
7.2.3 Europe Oral Anticoagulant Reversal Drug Market Share by Type (2018-2029)
7.3 Europe Oral Anticoagulant Reversal Drug Market Size by Application
7.3.1 Europe Oral Anticoagulant Reversal Drug Market Size by Application (2018-2024)
7.3.2 Europe Oral Anticoagulant Reversal Drug Market Size by Application (2024-2029)
7.3.3 Europe Oral Anticoagulant Reversal Drug Market Share by Application (2018-2029)
7.4 Europe Oral Anticoagulant Reversal Drug Market Size by Country
7.4.1 Europe Oral Anticoagulant Reversal Drug Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Oral Anticoagulant Reversal Drug Market Size by Country (2018-2024)
7.4.3 Europe Oral Anticoagulant Reversal Drug Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Oral Anticoagulant Reversal Drug Market Size (2018-2029)
8.2 China Oral Anticoagulant Reversal Drug Market Size by Type
8.2.1 China Oral Anticoagulant Reversal Drug Market Size by Type (2018-2024)
8.2.2 China Oral Anticoagulant Reversal Drug Market Size by Type (2024-2029)
8.2.3 China Oral Anticoagulant Reversal Drug Market Share by Type (2018-2029)
8.3 China Oral Anticoagulant Reversal Drug Market Size by Application
8.3.1 China Oral Anticoagulant Reversal Drug Market Size by Application (2018-2024)
8.3.2 China Oral Anticoagulant Reversal Drug Market Size by Application (2024-2029)
8.3.3 China Oral Anticoagulant Reversal Drug Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Oral Anticoagulant Reversal Drug Market Size (2018-2029)
9.2 Asia Oral Anticoagulant Reversal Drug Market Size by Type
9.2.1 Asia Oral Anticoagulant Reversal Drug Market Size by Type (2018-2024)
9.2.2 Asia Oral Anticoagulant Reversal Drug Market Size by Type (2024-2029)
9.2.3 Asia Oral Anticoagulant Reversal Drug Market Share by Type (2018-2029)
9.3 Asia Oral Anticoagulant Reversal Drug Market Size by Application
9.3.1 Asia Oral Anticoagulant Reversal Drug Market Size by Application (2018-2024)
9.3.2 Asia Oral Anticoagulant Reversal Drug Market Size by Application (2024-2029)
9.3.3 Asia Oral Anticoagulant Reversal Drug Market Share by Application (2018-2029)
9.4 Asia Oral Anticoagulant Reversal Drug Market Size by Region
9.4.1 Asia Oral Anticoagulant Reversal Drug Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Oral Anticoagulant Reversal Drug Market Size by Region (2018-2024)
9.4.3 Asia Oral Anticoagulant Reversal Drug Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Oral Anticoagulant Reversal Drug Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Oral Anticoagulant Reversal Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Oral Anticoagulant Reversal Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Oral Anticoagulant Reversal Drug Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Oral Anticoagulant Reversal Drug Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Oral Anticoagulant Reversal Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Oral Anticoagulant Reversal Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Oral Anticoagulant Reversal Drug Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Oral Anticoagulant Reversal Drug Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Oral Anticoagulant Reversal Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Oral Anticoagulant Reversal Drug Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Oral Anticoagulant Reversal Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Oral Anticoagulant Reversal Drug Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bausch Health Companies
11.1.1 Bausch Health Companies Company Details
11.1.2 Bausch Health Companies Business Overview
11.1.3 Bausch Health Companies Oral Anticoagulant Reversal Drug Introduction
11.1.4 Bausch Health Companies Revenue in Oral Anticoagulant Reversal Drug Business (2018-2024)
11.1.5 Bausch Health Companies Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Oral Anticoagulant Reversal Drug Introduction
11.2.4 Pfizer Revenue in Oral Anticoagulant Reversal Drug Business (2018-2024)
11.2.5 Pfizer Recent Developments
11.3 Fresenius Kabi
11.3.1 Fresenius Kabi Company Details
11.3.2 Fresenius Kabi Business Overview
11.3.3 Fresenius Kabi Oral Anticoagulant Reversal Drug Introduction
11.3.4 Fresenius Kabi Revenue in Oral Anticoagulant Reversal Drug Business (2018-2024)
11.3.5 Fresenius Kabi Recent Developments
11.4 Amneal Pharmaceuticals
11.4.1 Amneal Pharmaceuticals Company Details
11.4.2 Amneal Pharmaceuticals Business Overview
11.4.3 Amneal Pharmaceuticals Oral Anticoagulant Reversal Drug Introduction
11.4.4 Amneal Pharmaceuticals Revenue in Oral Anticoagulant Reversal Drug Business (2018-2024)
11.4.5 Amneal Pharmaceuticals Recent Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Oral Anticoagulant Reversal Drug Introduction
11.5.4 Boehringer Ingelheim Revenue in Oral Anticoagulant Reversal Drug Business (2018-2024)
11.5.5 Boehringer Ingelheim Recent Developments
11.6 CSL
11.6.1 CSL Company Details
11.6.2 CSL Business Overview
11.6.3 CSL Oral Anticoagulant Reversal Drug Introduction
11.6.4 CSL Revenue in Oral Anticoagulant Reversal Drug Business (2018-2024)
11.6.5 CSL Recent Developments
11.7 Octapharma
11.7.1 Octapharma Company Details
11.7.2 Octapharma Business Overview
11.7.3 Octapharma Oral Anticoagulant Reversal Drug Introduction
11.7.4 Octapharma Revenue in Oral Anticoagulant Reversal Drug Business (2018-2024)
11.7.5 Octapharma Recent Developments
11.8 Portola Pharmaceuticals
11.8.1 Portola Pharmaceuticals Company Details
11.8.2 Portola Pharmaceuticals Business Overview
11.8.3 Portola Pharmaceuticals Oral Anticoagulant Reversal Drug Introduction
11.8.4 Portola Pharmaceuticals Revenue in Oral Anticoagulant Reversal Drug Business (2018-2024)
11.8.5 Portola Pharmaceuticals Recent Developments
11.9 Perosphere Pharmaceuticals
11.9.1 Perosphere Pharmaceuticals Company Details
11.9.2 Perosphere Pharmaceuticals Business Overview
11.9.3 Perosphere Pharmaceuticals Oral Anticoagulant Reversal Drug Introduction
11.9.4 Perosphere Pharmaceuticals Revenue in Oral Anticoagulant Reversal Drug Business (2018-2024)
11.9.5 Perosphere Pharmaceuticals Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Oral Anticoagulant Reversal Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Prothrombin Complex Concentrates
Table 3. Key Players of Vitamin K
Table 4. Key Players of Protamine
Table 5. Key Players of Tranexamic Acid
Table 6. Global Oral Anticoagulant Reversal Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Oral Anticoagulant Reversal Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Oral Anticoagulant Reversal Drug Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Oral Anticoagulant Reversal Drug Market Share by Region (2018-2024)
Table 10. Global Oral Anticoagulant Reversal Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Oral Anticoagulant Reversal Drug Market Share by Region (2024-2029)
Table 12. Oral Anticoagulant Reversal Drug Market Trends
Table 13. Oral Anticoagulant Reversal Drug Market Drivers
Table 14. Oral Anticoagulant Reversal Drug Market Challenges
Table 15. Oral Anticoagulant Reversal Drug Market Restraints
Table 16. Global Oral Anticoagulant Reversal Drug Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Oral Anticoagulant Reversal Drug Revenue Share by Players (2018-2024)
Table 18. Global Top Oral Anticoagulant Reversal Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Anticoagulant Reversal Drug as of 2022)
Table 19. Global Oral Anticoagulant Reversal Drug Industry Ranking 2021 VS 2022 VS 2024
Table 20. Global 5 Largest Players Market Share by Oral Anticoagulant Reversal Drug Revenue (CR5 and HHI) & (2018-2024)
Table 21. Global Key Players of Oral Anticoagulant Reversal Drug, Headquarters and Area Served
Table 22. Global Key Players of Oral Anticoagulant Reversal Drug, Product and Application
Table 23. Global Key Players of Oral Anticoagulant Reversal Drug, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Oral Anticoagulant Reversal Drug Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Oral Anticoagulant Reversal Drug Revenue Market Share by Type (2018-2024)
Table 27. Global Oral Anticoagulant Reversal Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Oral Anticoagulant Reversal Drug Revenue Market Share by Type (2024-2029)
Table 29. Global Oral Anticoagulant Reversal Drug Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Oral Anticoagulant Reversal Drug Revenue Share by Application (2018-2024)
Table 31. Global Oral Anticoagulant Reversal Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Oral Anticoagulant Reversal Drug Revenue Share by Application (2024-2029)
Table 33. North America Oral Anticoagulant Reversal Drug Market Size by Type (2018-2024) & (US$ Million)
Table 34. North America Oral Anticoagulant Reversal Drug Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Oral Anticoagulant Reversal Drug Market Size by Application (2018-2024) & (US$ Million)
Table 36. North America Oral Anticoagulant Reversal Drug Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Oral Anticoagulant Reversal Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Oral Anticoagulant Reversal Drug Market Size by Country (2018-2024) & (US$ Million)
Table 39. North America Oral Anticoagulant Reversal Drug Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Oral Anticoagulant Reversal Drug Market Size by Type (2018-2024) & (US$ Million)
Table 41. Europe Oral Anticoagulant Reversal Drug Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Oral Anticoagulant Reversal Drug Market Size by Application (2018-2024) & (US$ Million)
Table 43. Europe Oral Anticoagulant Reversal Drug Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Oral Anticoagulant Reversal Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Oral Anticoagulant Reversal Drug Market Size by Country (2018-2024) & (US$ Million)
Table 46. Europe Oral Anticoagulant Reversal Drug Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Oral Anticoagulant Reversal Drug Market Size by Type (2018-2024) & (US$ Million)
Table 48. China Oral Anticoagulant Reversal Drug Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Oral Anticoagulant Reversal Drug Market Size by Application (2018-2024) & (US$ Million)
Table 50. China Oral Anticoagulant Reversal Drug Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Oral Anticoagulant Reversal Drug Market Size by Type (2018-2024) & (US$ Million)
Table 52. Asia Oral Anticoagulant Reversal Drug Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Oral Anticoagulant Reversal Drug Market Size by Application (2018-2024) & (US$ Million)
Table 54. Asia Oral Anticoagulant Reversal Drug Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Oral Anticoagulant Reversal Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Oral Anticoagulant Reversal Drug Market Size by Region (2018-2024) & (US$ Million)
Table 57. Asia Oral Anticoagulant Reversal Drug Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Oral Anticoagulant Reversal Drug Market Size by Type (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Oral Anticoagulant Reversal Drug Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Oral Anticoagulant Reversal Drug Market Size by Application (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Oral Anticoagulant Reversal Drug Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Oral Anticoagulant Reversal Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Oral Anticoagulant Reversal Drug Market Size by Country (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Oral Anticoagulant Reversal Drug Market Size by Country (2024-2029) & (US$ Million)
Table 65. Bausch Health Companies Company Details
Table 66. Bausch Health Companies Business Overview
Table 67. Bausch Health Companies Oral Anticoagulant Reversal Drug Product
Table 68. Bausch Health Companies Revenue in Oral Anticoagulant Reversal Drug Business (2018-2024) & (US$ Million)
Table 69. Bausch Health Companies Recent Developments
Table 70. Pfizer Company Details
Table 71. Pfizer Business Overview
Table 72. Pfizer Oral Anticoagulant Reversal Drug Product
Table 73. Pfizer Revenue in Oral Anticoagulant Reversal Drug Business (2018-2024) & (US$ Million)
Table 74. Pfizer Recent Developments
Table 75. Fresenius Kabi Company Details
Table 76. Fresenius Kabi Business Overview
Table 77. Fresenius Kabi Oral Anticoagulant Reversal Drug Product
Table 78. Fresenius Kabi Revenue in Oral Anticoagulant Reversal Drug Business (2018-2024) & (US$ Million)
Table 79. Fresenius Kabi Recent Developments
Table 80. Amneal Pharmaceuticals Company Details
Table 81. Amneal Pharmaceuticals Business Overview
Table 82. Amneal Pharmaceuticals Oral Anticoagulant Reversal Drug Product
Table 83. Amneal Pharmaceuticals Revenue in Oral Anticoagulant Reversal Drug Business (2018-2024) & (US$ Million)
Table 84. Amneal Pharmaceuticals Recent Developments
Table 85. Boehringer Ingelheim Company Details
Table 86. Boehringer Ingelheim Business Overview
Table 87. Boehringer Ingelheim Oral Anticoagulant Reversal Drug Product
Table 88. Boehringer Ingelheim Revenue in Oral Anticoagulant Reversal Drug Business (2018-2024) & (US$ Million)
Table 89. Boehringer Ingelheim Recent Developments
Table 90. CSL Company Details
Table 91. CSL Business Overview
Table 92. CSL Oral Anticoagulant Reversal Drug Product
Table 93. CSL Revenue in Oral Anticoagulant Reversal Drug Business (2018-2024) & (US$ Million)
Table 94. CSL Recent Developments
Table 95. Octapharma Company Details
Table 96. Octapharma Business Overview
Table 97. Octapharma Oral Anticoagulant Reversal Drug Product
Table 98. Octapharma Revenue in Oral Anticoagulant Reversal Drug Business (2018-2024) & (US$ Million)
Table 99. Octapharma Recent Developments
Table 100. Portola Pharmaceuticals Company Details
Table 101. Portola Pharmaceuticals Business Overview
Table 102. Portola Pharmaceuticals Oral Anticoagulant Reversal Drug Product
Table 103. Portola Pharmaceuticals Revenue in Oral Anticoagulant Reversal Drug Business (2018-2024) & (US$ Million)
Table 104. Portola Pharmaceuticals Recent Developments
Table 105. Perosphere Pharmaceuticals Company Details
Table 106. Perosphere Pharmaceuticals Business Overview
Table 107. Perosphere Pharmaceuticals Oral Anticoagulant Reversal Drug Product
Table 108. Perosphere Pharmaceuticals Revenue in Oral Anticoagulant Reversal Drug Business (2018-2024) & (US$ Million)
Table 109. Perosphere Pharmaceuticals Recent Developments
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Anticoagulant Reversal Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Oral Anticoagulant Reversal Drug Market Share by Type: 2022 VS 2029
Figure 3. Prothrombin Complex Concentrates Features
Figure 4. Vitamin K Features
Figure 5. Protamine Features
Figure 6. Tranexamic Acid Features
Figure 7. Global Oral Anticoagulant Reversal Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Oral Anticoagulant Reversal Drug Market Share by Application: 2022 VS 2029
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Others Case Studies
Figure 12. Oral Anticoagulant Reversal Drug Report Years Considered
Figure 13. Global Oral Anticoagulant Reversal Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Oral Anticoagulant Reversal Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Oral Anticoagulant Reversal Drug Market Share by Region: 2022 VS 2029
Figure 16. Global Oral Anticoagulant Reversal Drug Market Share by Players in 2022
Figure 17. Global Top Oral Anticoagulant Reversal Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Anticoagulant Reversal Drug as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Oral Anticoagulant Reversal Drug Revenue in 2022
Figure 19. North America Oral Anticoagulant Reversal Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Oral Anticoagulant Reversal Drug Market Share by Type (2018-2029)
Figure 21. North America Oral Anticoagulant Reversal Drug Market Share by Application (2018-2029)
Figure 22. North America Oral Anticoagulant Reversal Drug Market Share by Country (2018-2029)
Figure 23. United States Oral Anticoagulant Reversal Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Oral Anticoagulant Reversal Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Oral Anticoagulant Reversal Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Oral Anticoagulant Reversal Drug Market Share by Type (2018-2029)
Figure 27. Europe Oral Anticoagulant Reversal Drug Market Share by Application (2018-2029)
Figure 28. Europe Oral Anticoagulant Reversal Drug Market Share by Country (2018-2029)
Figure 29. Germany Oral Anticoagulant Reversal Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Oral Anticoagulant Reversal Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Oral Anticoagulant Reversal Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Oral Anticoagulant Reversal Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Oral Anticoagulant Reversal Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Oral Anticoagulant Reversal Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Oral Anticoagulant Reversal Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Oral Anticoagulant Reversal Drug Market Share by Type (2018-2029)
Figure 37. China Oral Anticoagulant Reversal Drug Market Share by Application (2018-2029)
Figure 38. Asia Oral Anticoagulant Reversal Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Oral Anticoagulant Reversal Drug Market Share by Type (2018-2029)
Figure 40. Asia Oral Anticoagulant Reversal Drug Market Share by Application (2018-2029)
Figure 41. Asia Oral Anticoagulant Reversal Drug Market Share by Region (2018-2029)
Figure 42. Japan Oral Anticoagulant Reversal Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Oral Anticoagulant Reversal Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Oral Anticoagulant Reversal Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Oral Anticoagulant Reversal Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Oral Anticoagulant Reversal Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Oral Anticoagulant Reversal Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Oral Anticoagulant Reversal Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Oral Anticoagulant Reversal Drug Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Oral Anticoagulant Reversal Drug Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Oral Anticoagulant Reversal Drug Market Share by Country (2018-2029)
Figure 52. Brazil Oral Anticoagulant Reversal Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Oral Anticoagulant Reversal Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Oral Anticoagulant Reversal Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Oral Anticoagulant Reversal Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Oral Anticoagulant Reversal Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Oral Anticoagulant Reversal Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Bausch Health Companies Revenue Growth Rate in Oral Anticoagulant Reversal Drug Business (2018-2024)
Figure 59. Pfizer Revenue Growth Rate in Oral Anticoagulant Reversal Drug Business (2018-2024)
Figure 60. Fresenius Kabi Revenue Growth Rate in Oral Anticoagulant Reversal Drug Business (2018-2024)
Figure 61. Amneal Pharmaceuticals Revenue Growth Rate in Oral Anticoagulant Reversal Drug Business (2018-2024)
Figure 62. Boehringer Ingelheim Revenue Growth Rate in Oral Anticoagulant Reversal Drug Business (2018-2024)
Figure 63. CSL Revenue Growth Rate in Oral Anticoagulant Reversal Drug Business (2018-2024)
Figure 64. Octapharma Revenue Growth Rate in Oral Anticoagulant Reversal Drug Business (2018-2024)
Figure 65. Portola Pharmaceuticals Revenue Growth Rate in Oral Anticoagulant Reversal Drug Business (2018-2024)
Figure 66. Perosphere Pharmaceuticals Revenue Growth Rate in Oral Anticoagulant Reversal Drug Business (2018-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries